The MAPK inhibitors market is projected to reach $5.22 billion by 2030 at an 11.3% CAGR, driven by targeted oncology therapies and personalized cancer care growth.
Read More
The mRNA manufacturing service market is projected to reach $12.97 billion by 2030 at a 16.2% CAGR, driven by therapy trials, outsourcing demand, and GMP-scale production.
Read More
The mRNA and next-generation vaccine platforms market is set to reach $82.61 billion by 2030 at a 15.8% CAGR, driven by cancer vaccines and rapid platform innovation.
Read More
The mRNA vaccine CDMO market is projected to reach $17.1 billion by 2030 at a 15.3% CAGR, fueled by cancer vaccine growth, rapid scale-up, and integrated mRNA services.
Read More
The lipid nanoparticle delivery system market is set to reach $4.19 billion by 2030 at a 15.5% CAGR, driven by mRNA therapies, gene drugs, and precision medicine growth.
Read More
Menopausal disorder treatment market to reach $16.26 billion by 2030 at 7.2% CAGR, driven by rising demand for hormone replacement therapies.
Read More
Meningococcal vaccines market to reach $6.58 billion by 2030 at 9.1% CAGR, driven by increase in healthcare spending.
Read More
Memantine hcl market to reach $1.71 billion by 2030 at 6.7% CAGR, driven by rising incidence of alzheimer’s disease and growing demand for personalized medicine.
Read More
Melatonin supplements market to reach $4.89 billion by 2030 at 12.2% CAGR, driven by rising prevalence of sleep disorders.
Read More
Melanoma Therapeutics Market Performance Outlook 2026–2030: Revenue to Hit $7.49 Billion at 11% CAGR
Melanoma therapeutics market to reach $7.49 billion by 2030 at 11.0% CAGR, driven by increasing incidence of melanoma.
Read More